GammaDelta’s Scientific Co-Founder Adrian Hayday Receives Inaugural Business of Science Leadership Award

News

GammaDelta Therapeutics will be keeping the global community updated with news about their pioneering research and development for the exploitation of tissue derived γδ T cells.